Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TPLF-4 for Locally Advanced SCCHN
NCT00139230Phase 2Completed
- Sponsor
- Dana-Farber Cancer Institute
- Start
- Jan 1997
- Primary completion
- Dec 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of docetaxel in squamous cell carcinoma of the head and neck (HNSCC), sponsored by Dana-Farber Cancer Institute. Started Jan 1997; status: completed.
02
Drugs
docetaxel
03
Conditions
squamous cell carcinoma of the head and neck (HNSCC)
Beyond the preview
Go deeper on NCT00139230.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00139230.